Strattera Withdrawal: Symptoms, Timeline, and Safe Discontinuation

Strattera Discontinuation: What to Expect

Strattera (atomoxetine) is a non-stimulant ADHD medication that works by inhibiting norepinephrine reuptake. When discontinued after regular use, it produces a cluster of withdrawal-like symptoms known as discontinuation syndrome. These symptoms are not life-threatening but are uncomfortable enough to derail treatment plans if you are not prepared.

Atomoxetine has a half-life of approximately 5 hours (21 hours in poor metabolizers). Discontinuation symptoms typically begin within 1 to 2 days of the last dose and peak within the first week.

Common Discontinuation Symptoms

• Fatigue: The most frequently reported symptom. Energy levels drop significantly in the first week.
• Irritability and mood swings: Norepinephrine levels shift, affecting emotional regulation.
• Difficulty concentrating: ADHD symptoms return, often feeling worse than before treatment (rebound effect).
• Nausea and stomach upset: GI symptoms are common in the first 3 to 5 days.
• Headaches: Tension-type headaches occur in approximately 20% of people who stop abruptly.
• Dizziness: Especially when standing up quickly.
• Insomnia or excessive sleepiness: Sleep patterns disrupt in both directions.

Withdrawal Timeline

1. Days 1 to 3: Onset of fatigue, irritability, and ADHD symptom rebound. Nausea and headaches begin.
2. Days 4 to 7: Peak symptom intensity. Concentration difficulties are worst during this period. Mood instability is most pronounced.
3. Weeks 2 to 3: Physical symptoms (nausea, headaches, dizziness) resolve. Fatigue and concentration issues gradually improve.
4. Weeks 4 to 6: Most people return to their pre-Strattera baseline. ADHD symptoms stabilize at their untreated level.

The FDA labeling for atomoxetine does not include a formal discontinuation protocol, but prescribing guidelines from the American Academy of Child and Adolescent Psychiatry recommend gradual dose reduction over 1 to 2 weeks when stopping the medication.

Why Tapering Matters

Abruptly stopping Strattera forces the brain to adjust to the sudden absence of norepinephrine reuptake inhibition. The norepinephrine system has adapted to the drug’s presence. Removing it suddenly creates a temporary deficit. Tapering gives the brain time to readjust gradually.

A Sample Taper Schedule

For a patient taking 80 mg daily:

• Week 1: Reduce to 60 mg daily
• Week 2: Reduce to 40 mg daily
• Week 3: Reduce to 25 mg daily
• Week 4: Discontinue

Your prescriber will adjust this schedule based on your dose, duration of use, and individual response. Do not modify your dose without medical guidance.

Strattera vs Stimulant Withdrawal

Strattera withdrawal differs from stimulant (Adderall, Ritalin) withdrawal in important ways:

• No crash: Stimulant withdrawal produces a dramatic crash with severe fatigue and depression. Strattera withdrawal is more gradual.
• No cravings: Strattera does not activate the reward system. There is no compulsion to resume use.
• No abuse potential: Strattera is not a controlled substance. It does not produce euphoria.
• Longer timeline: Stimulant withdrawal peaks in 1 to 3 days. Strattera discontinuation symptoms may take 1 to 2 weeks to peak.

Managing Symptoms During Discontinuation

• Sleep hygiene: Maintain consistent sleep and wake times. Avoid caffeine after noon.
• Exercise: Physical activity boosts norepinephrine naturally and reduces fatigue.
• Nutrition: Eat regular meals. Blood sugar fluctuations worsen irritability and concentration issues.
• Caffeine (modest): A small amount of caffeine offsets fatigue. Avoid excessive intake, which worsens anxiety and insomnia.
• Communicate: Tell your family, employer, or school that you are adjusting medications. Reduced performance during this period is temporary.

When to Call Your Doctor

Contact your prescriber if you experience severe depression, suicidal thoughts, or symptoms that worsen after the first week instead of improving. The FDA includes a boxed warning about increased suicidal thinking in children and young adults taking atomoxetine. This risk persists during discontinuation.

If you need ADHD treatment alternatives after stopping Strattera, your prescriber can discuss stimulant medications, guanfacine (Intuniv), clonidine, or behavioral strategies.